Abman S H, Wolfe R R, Accurso F J, Koops B L, Bowman C M, Wiggins J W
Pediatrics. 1985 Jan;75(1):80-4.
The cardiac catheterization data of six infants with bronchopulmonary dysplasia (BPD) were reviewed to examine the responsiveness of their pulmonary vascular beds to changes in oxygen tension. The infants were studied because of slow recovery from their oxygen requirements and clinical evidence of persistent pulmonary hypertension. All were receiving home oxygen therapy and had abnormal chest radiographs and right ventricular hypertrophy by ECG at the time of catheterization (mean age, 25 months). All infants had mean pulmonary artery pressure greater than 25 mm Hg in room air, with a mean of 48 mm Hg. All decreased mean pulmonary artery pressure by at least 10 mm Hg when placed in high levels of inspired oxygen (FiO2 greater than 80), with a mean pulmonary artery pressure of 25 mm Hg. This represented a significant decrease in mean pulmonary artery pressure from room air pressures (P less than .005). Mean pulmonary artery pressure was also measured in three infants who were breathing supplemental oxygen by nasal cannula at flow rates similar to levels used for outpatient therapy. Most of the reduction in mean pulmonary artery pressure that occurred at high FiO2 occurred at these lower flow rates of supplemental oxygen. It is concluded that infants with bronchopulmonary dysplasia who have pulmonary hypertension generally have reactive pulmonary vascular beds, responsive to supplemental oxygen. Continuous oxygen therapy by nasal cannula may be useful in the treatment of pulmonary hypertension associated with bronchopulmonary dysplasia.
回顾了6例支气管肺发育不良(BPD)婴儿的心脏导管插入术数据,以检查其肺血管床对氧张力变化的反应性。这些婴儿因氧需求恢复缓慢以及存在持续性肺动脉高压的临床证据而接受研究。所有婴儿在导管插入术时(平均年龄25个月)均接受家庭氧疗,胸部X线片异常,心电图显示右心室肥大。所有婴儿在室内空气中平均肺动脉压均大于25 mmHg,平均为48 mmHg。当吸入高浓度氧气(FiO2大于80)时,所有婴儿的平均肺动脉压至少降低10 mmHg,平均肺动脉压为25 mmHg。这表明与室内空气压力相比,平均肺动脉压有显著降低(P小于0.005)。还对3例通过鼻导管以类似于门诊治疗所用流速吸入补充氧气的婴儿测量了平均肺动脉压。在高FiO2时发生的平均肺动脉压的大部分降低发生在这些较低流速的补充氧气情况下。结论是,患有肺动脉高压的支气管肺发育不良婴儿通常具有反应性肺血管床,对补充氧气有反应。通过鼻导管持续氧疗可能对治疗与支气管肺发育不良相关的肺动脉高压有用。